This hedge fund is so optimistic about COVID-19 that they’re short Clorox [In-Depth] – ValueWalk Premium
coronavirus

This hedge fund is so optimistic about COVID-19 that they’re short Clorox [In-Depth]

A lot has happened since the coronavirus pandemic began, but aside from the temporary selloff in March, the stock market has continued to hum along as if nothing has been happening. There's no denying that the financial markets have been changed by the pandemic, and investors should be thinking differently when it comes to investing right now.

Q2 2020 hedge fund letters, conferences and more


Imperfect data
Management at David Capital Partners wrote a detailed analysis of their view of the impact of COVID-19 on investing and the markets

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0